Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zihan Tang

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Nature Communications|January 16, 2023
Hyperaminoacidemia induces pancreatic α cell proliferation via synergism between the mTORC1 and CaSR-Gq signaling pathwaysYulong Gong, Bingyuan Yang, Dingdong Zhang, et al.
Clinical Immunology (Orlando, Fla.)|September 25, 2023
Risk factors in antiphospholipid antibody-associated valvular heart disease: A 383-patient cohort studyHaoyu Pan, Zetao Ding, Zhixia Yang, et al.
Iscience|December 25, 2024
Hyperaminoacidemia from interrupted glucagon signaling increases pancreatic acinar cell proliferation and size via mTORC1 and YAP pathwaysChunhua Dai, Yue Zhang, Yulong Gong, et al.
Rheumatology (Oxford, England)|July 22, 2022
COVID-19 vaccine affects neither prothrombotic antibody profile nor thrombosis in primary anti-phospholipid syndrome: a prospective studyHaoyu Pan, Zihan Tang, Jialin Teng, et al.
Frontiers in Immunology|February 8, 2021
Cytokine Storm in Coronavirus Disease 2019 and Adult-Onset Still's Disease: Similarities and DifferencesJianfen Meng, Yuning Ma, Jinchao Jia, et al.
Rheumatology (Oxford, England)|October 25, 2022
Inactivated SARS-CoV-2 vaccine does not increase the risk of relapse in patients with clinically inactive adult-onset Still's diseaseXinyue Hong, Haoyu Pan, Yutong Su, et al.
Rheumatology (Oxford, England)|September 27, 2023
The landscape of innate and adaptive immune cell subsets in patients with adult-onset Still's diseaseHuihui Chi, Xinyue Hong, Ningqi Dai, et al.
Nature Communications|August 21, 2023
CD36 mediates SARS-CoV-2-envelope-protein-induced platelet activation and thrombosisZihan Tang, Yanyan Xu, Yun Tan, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Nature Communications|January 16, 2023
Hyperaminoacidemia induces pancreatic α cell proliferation via synergism between the mTORC1 and CaSR-Gq signaling pathwaysYulong Gong, Bingyuan Yang, Dingdong Zhang, et al.
Clinical Immunology (Orlando, Fla.)|September 25, 2023
Risk factors in antiphospholipid antibody-associated valvular heart disease: A 383-patient cohort studyHaoyu Pan, Zetao Ding, Zhixia Yang, et al.
Iscience|December 25, 2024
Hyperaminoacidemia from interrupted glucagon signaling increases pancreatic acinar cell proliferation and size via mTORC1 and YAP pathwaysChunhua Dai, Yue Zhang, Yulong Gong, et al.
Rheumatology (Oxford, England)|July 22, 2022
COVID-19 vaccine affects neither prothrombotic antibody profile nor thrombosis in primary anti-phospholipid syndrome: a prospective studyHaoyu Pan, Zihan Tang, Jialin Teng, et al.
Frontiers in Immunology|February 8, 2021
Cytokine Storm in Coronavirus Disease 2019 and Adult-Onset Still's Disease: Similarities and DifferencesJianfen Meng, Yuning Ma, Jinchao Jia, et al.
Rheumatology (Oxford, England)|October 25, 2022
Inactivated SARS-CoV-2 vaccine does not increase the risk of relapse in patients with clinically inactive adult-onset Still's diseaseXinyue Hong, Haoyu Pan, Yutong Su, et al.
Rheumatology (Oxford, England)|September 27, 2023
The landscape of innate and adaptive immune cell subsets in patients with adult-onset Still's diseaseHuihui Chi, Xinyue Hong, Ningqi Dai, et al.
Nature Communications|August 21, 2023
CD36 mediates SARS-CoV-2-envelope-protein-induced platelet activation and thrombosisZihan Tang, Yanyan Xu, Yun Tan, et al.
Pageof 8